VIATRIS INC (VIA.DE) Stock Price & Overview
FRA:VIA • US92556V1061
Current stock price
The current stock price of VIA.DE is 11.676 EUR. Today VIA.DE is up by 0.67%. In the past month the price decreased by -4.72%. In the past year, price increased by 82.55%.
VIA.DE Key Statistics
- Market Cap
- 13.444B
- P/E
- 5.78
- Fwd P/E
- 5.44
- EPS (TTM)
- 2.02
- Dividend Yield
- 3.68%
VIA.DE Stock Performance
VIA.DE Stock Chart
VIA.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to VIA.DE. When comparing the yearly performance of all stocks, VIA.DE is one of the better performing stocks in the market, outperforming 92.64% of all stocks.
VIA.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VIA.DE. VIA.DE may be in some trouble as it scores bad on both profitability and health.
VIA.DE Earnings
On February 26, 2026 VIA.DE reported an EPS of 0.57 and a revenue of 3.70B. The company beat EPS expectations (4.82% surprise) and beat revenue expectations (2.79% surprise).
VIA.DE Forecast & Estimates
18 analysts have analysed VIA.DE and the average price target is 11.97 EUR. This implies a price increase of 2.54% is expected in the next year compared to the current price of 11.676.
For the next year, analysts expect an EPS growth of 6.3% and a revenue growth 3.64% for VIA.DE
VIA.DE Groups
Sector & Classification
VIA.DE Financial Highlights
Over the last trailing twelve months VIA.DE reported a non-GAAP Earnings per Share(EPS) of 2.02. The EPS decreased by -10.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.45% | ||
| ROE | -23.89% | ||
| Debt/Equity | 0.85 |
VIA.DE Ownership
VIA.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.46 | 98.09B | ||
| 1SAN | SANOFI | 9.5 | 97.617B | ||
| SNW | SANOFI | 9.46 | 97.52B | ||
| UCB | UCB SA | 26.74 | 52.868B | ||
| UNC | UCB SA | 26.6 | 51.818B | ||
| MRK | MERCK KGAA | 13.53 | 48.435B | ||
| 1MRK | MERCK KGAA | 12.99 | 46.695B | ||
| 1BAYN | BAYER AG-REG | 8.66 | 39.808B | ||
| BAYN | BAYER AG-REG | 8.57 | 39.739B | ||
| IPN | IPSEN | 14 | 13.636B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.04 | 10.185B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.908B | ||
| VIRP | VIRBAC SA | 16.72 | 2.978B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About VIA.DE
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 30,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Company Info
IPO: 1973-02-01
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA US
Employees: 30000
Phone: 17245141465
VIATRIS INC / VIA.DE FAQ
What does VIA do?
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 30,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
What is the stock price of VIATRIS INC today?
The current stock price of VIA.DE is 11.676 EUR. The price increased by 0.67% in the last trading session.
What is the dividend status of VIATRIS INC?
VIATRIS INC (VIA.DE) has a dividend yield of 3.68%. The yearly dividend amount is currently 0.42.
What is the ChartMill technical and fundamental rating of VIA stock?
VIA.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for VIATRIS INC?
VIATRIS INC (VIA.DE) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of VIA stock?
VIATRIS INC (VIA.DE) has a market capitalization of 13.44B EUR. This makes VIA.DE a Large Cap stock.
Who owns VIATRIS INC?
You can find the ownership structure of VIATRIS INC (VIA.DE) on the Ownership tab.